|Partial Close, 12/2012 ||$1.5M|
|Product Crowdfunding, 10/2013 ||£1M|
|Debt, 12/2010 ||$600k|
|Debt, 2/2012 ||$200k|
Phraxis, Incorporated, a medical device company, develops treatment solutions for patients who need vascular access to enable hemodialysis. The company offers InterGraft, a percutaneously delivered arterio-venous shunt that provides a non-surgical approach for patients who need vascular access. It also develops devices for interventional nephrology to enable physicians to manage their dialysis patients. The company was incorporated in 2008 and is based in St. Paul, Minnesota.